Printer Friendly

Novel and Advanced Products and Technologies to Boost Electrical Stimulation Devices Market to USD 5.2 Billion by 2020, Reports iHealthcareAnalyst, Inc..

Maryland Heights, MO, September 06, 2016 --(PR.com)-- The global electrical stimulation devices market is estimated to reach USD 5.2 Billion in 2020, growing at a CAGR of 4.9% from 2016 to 2020, according to a market research report Electrical Stimulation Devices Market 2013-2020, published by iHealthcareAnalyst, Inc.

Visit the Electrical Stimulation Devices Market 2013-2020 report at http://www.ihealthcareanalyst.com/report/electrical-stimulation-devices-market/

The global electrical stimulation devices market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).

Electrical stimulation devices such as electrical muscle stimulation (EMS), or neuromuscular electrical stimulation (NMES) or electromyostimulation elicits muscle contraction using electric impulses. They are to serve as a strength training tool for healthy subjects and athletes, a rehabilitation and preventive tool for partially or totally immobilized patients, a testing tool for evaluating the neural and/or muscular function in vivo, and a post-exercise recovery tool for athletes. The impulses are generated by a device and delivered through electrodes on the skin in direct proximity to the muscles to be stimulated. The impulses mimic the action potential coming from the central nervous system, causing the muscles to contract. The electrodes are generally pads that adhere to the skin.

The global electrical stimulation devices market segmentation is based on product types (Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices, Gastric Electrical Stimulation (GES) Devices, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Neuromuscular Electrical Stimulation (NMES/EMS) Devices, Other Devices (Electrotherapy Devices, Combination Devices, TNS, TMS, etc.), and its applications (Pain Management, Neurological and Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management, Incontinence Management, esthetics, training, wound healing, cosmetics). The global electrical stimulation devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global electrical stimulation devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

1. Device Type

1.1. Deep Brain Stimulation (DBS) Devices

1.2. Gastric Electrical Stimulation (GES) Devices

1.3. Neuromuscular Electrical Stimulation (NMES/EMS) Devices

1.4. Sacral Nerve Stimulation (SNS) Devices

1.5. Spinal Cord Stimulation (SCS) Devices

1.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices

1.7. Vagus Nerve Stimulation (VNS) Devices

1.8. Others (Electrotherapy Devices, Combination Devices, TNS, TMS, etc.)

2. Application

2.1. Incontinence Management

2.2. Metabolism & GIT Management

2.3. Musculoskeletal Disorder Management

2.4. Neurological and Movement Disorder Management

2.5. Pain Management

2.6. Others (esthetics, training, wound healing, cosmetics, etc.)

3. Geography (Region, Country)

3.1. North America (U.S., Canada)

3.2. Latin America (Brazil, Mexico, Rest of LA)

3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)

3.4. Asia Pacific (Japan, China, India, Rest of APAC)

3.5. Rest of the World

4. Company Profiles

4.1. Boston Scientific Corporation

4.2. BTL Industries, Inc.

4.3. Cyberonics, Inc.

4.4. DJO Global, Inc.

4.5. Medtronic plc

4.6. Nevro Corporation

4.7. NeuroMetrix, Inc.

4.8. St. Jude Medical, Inc.

4.9. Uroplasty, Inc. (Cogentix Medical)

4.10. Zynex, Inc.

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.

2109, Mckelvey Hill Drive,

Maryland Heights, MO 63043

United States

Email: sales@ihealthcareranalyst.com

Website: http://www.ihealthcareanalyst.com

Contact Information:

iHealthcareAnalyst, Inc.

Ana Aitawa

(314) 736-9294

Contact via Email

http://www.ihealthcareanalyst.com/

Read the full story here: http://www.pr.com/press-release/686239
COPYRIGHT 2016 PR.com
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR.com (Press Releases)
Date:Sep 6, 2016
Words:703
Previous Article:Adoption of Laboratory Scale Models and Contract Research Services to Boost Cell Culture Market to USD 4.7 Billion by 2020, Published by...
Next Article:Announcing WhirrNet: the World's First Drone Ad Network.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters